FDA Accepts Supplemental Application for Macitentan by Seasons Biotech
The FDA has accepted a supplemental application for Macitentan submitted by Seasons Biotech.
Company
Pharmaceutical intelligence for Seasons Biotech with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.